Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechnikov Probiotics for Anterior Resection Syndrome in Colon Cancer
NCT03531606Completed
- Start
- Dec 2016
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms). Primary endpoint: Anterior resection syndrome improvement change. Started Dec 2016; status: completed.
Beyond the preview
Go deeper on NCT03531606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03531606.